IIH causes increased pressure around the brain without an obvious cause, leading to headache and vision problems.
✦ AI summary
Research on Idiopathic Intracranial Hypertension (IIH) is exploring both what causes it and how to manage it. Some studies point to immune system changes and specific protein/cytokine patterns in blood and spinal fluid that may help explain the condition and could one day serve as diagnostic markers [1][9]. Others look at the brain's fluid drainage system, suggesting that blood flow through veins in the brain affects pressure regulation and fluid clearance, which may relate to the vein narrowing sometimes seen in IIH [11], and researchers are also refining imaging techniques to better visualize these veins [12].
On the treatment side, weight loss is described as an established way to improve IIH, and GLP-1 receptor agonist medications (a newer class of weight-loss drugs) are being studied for their potential to reduce pressure and possibly lower the chance of spinal fluid leaks, though researchers note the evidence is still early and larger studies are needed [2][3][8]. Other work focuses on improving diagnosis and monitoring, including MRI measurements that change with treatment in children [10], eye imaging methods to distinguish true swelling of the optic nerve from look-alike conditions [4], and cheaper virtual-re
This is an AI-generated summary of the sources below — not medical advice. Always talk to a doctor or pharmacist about your own situation.
Cytokine levels in serum and cerebrospinal fluid of patients with idiopathic intracranial hypertension.
Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure (ICP) without an identifiable intracranial lesion, yet its underlying pathophysiology remains poorly defined. Emerging evidence suggests that immune-mediated mechanisms may contribute to disease onset and p…
Optical coherence tomography measurement of retinal layers above the peripapillary hyperreflective ovoid mass-like structure in true papilloedema and pseudo-papilloedema.
Discriminating between true papilloedema and pseudo-papilloedema is crucial, as true papilloedema can be both vision- and life-threatening. To test a simple method for differentiating pseudo-papilloedema from true papilloedema in patients with peripapillary hyperreflective ovoid mass-like structures…
Reduction of Cerebrospinal Fluid Leaks in Idiopathic Intracranial Hypertension with Glucagon-like Peptide-1 Receptor Agonist Use.
Elevated intracranial pressure (ICP) secondary to idiopathic intracranial hypertension (IIH) is a recognized risk factor for anterior and lateral skull base cerebrospinal fluid (CSF) leaks. A recent randomized controlled trial (Mitchell et al) demonstrated a significant reduction of ICP in IIH with…
Comparison of clinical profiles of idiopathic intracranial hypertension in patients with and without anemia.
To compare the demographic, clinical, visual, and structural parameters in idiopathic intracranial hypertension (IIH) patients with and without anemia. This was a prospective comparative clinical study conducted at a tertiary eye care center. Patients fulfilling the modified Dandy criteria for IIH w…
Comparison of virtual reality-based portable perimetry and conventional perimetry in patients with idiopathic intracranial hypertension.
To compare a newly developed virtual reality-based perimeter (Oculera visual field analyzer) with the Humphrey Field Analyzer (HFA) in patients with idiopathic intracranial hypertension (IIH). A cross-sectional study. In this study, 30 eyes of 15 IIH patients were randomly tested with HFA (24-2, SIT…
Diagnostic delay in patients with myelin oligodendrocyte antibody-associated disease presenting with elevated intracranial pressure.
Elevated intracranial pressure (ICP) is a recently recognized complication of myelin oligodendrocyte antibody associated disease (MOGAD). We describe 5 patients with MOGAD presenting with elevated ICP. Serum MOG antibody testing completed at the University of Vermont Medical Center between January 1…
Idiopathic Intracranial Hypertension Is Characterized by a Distinct Proteomic Profile.
The pathophysiology of idiopathic intracranial hypertension (IIH) is poorly understood and disease-specific biomarkers are lacking. We aimed to shed light on IIH pathophysiology and identify disease-specific biomarkers. This prospective cross-sectional cohort study included patients with new-onset I…